Workflow
生物耗材
icon
Search documents
泰坦科技股价涨9.83%,诺德基金旗下1只基金重仓,持有5.51万股浮盈赚取13.89万元
Xin Lang Cai Jing· 2026-01-12 01:54
1月12日,泰坦科技涨9.83%,截至发稿,报28.16元/股,成交1598.25万元,换手率0.35%,总市值46.31 亿元。 资料显示,上海泰坦科技股份有限公司位于上海市奉贤区环城西路3111弄258号,成立日期2007年10月 18日,上市日期2020年10月30日,公司主营业务涉及为创新研发、生产质控实验室提供科学服务一站式 技术集成解决方案,具体包括科研试剂、生物耗材、分析耗材、实验仪器、智能实验设备、科研信息 化、特种化学品及相关综合技术服务等产品与服务。主营业务收入构成为:科研试剂42.70%,科研仪 器及耗材28.42%,特种化学品26.48%,实验室建设及科研信息化2.37%,其他(补充)0.02%。 诺德量化核心A(006267)基金经理为王恒楠。 截至发稿,王恒楠累计任职时间7年54天,现任基金资产总规模2.45亿元,任职期间最佳基金回报 59.71%, 任职期间最差基金回报-35.81%。 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 责任编辑 ...
泰坦科技跌2.04%,成交额5021.25万元,主力资金净流出408.18万元
Xin Lang Cai Jing· 2025-10-14 02:58
Company Overview - Titan Technology Co., Ltd. is located at 89 Shilong Road, Xuhui District, Shanghai, established on October 18, 2007, and listed on October 30, 2020 [1] - The company provides integrated technical solutions for scientific services, including research reagents, biological consumables, analytical consumables, laboratory instruments, smart laboratory equipment, research information technology, specialty chemicals, and related comprehensive technical services [1] Financial Performance - For the first half of 2025, Titan Technology achieved operating revenue of 1.219 billion yuan, a year-on-year decrease of 12.70%, while the net profit attributable to shareholders increased by 91.55% to 9.7652 million yuan [2] - The company has distributed a total of 86.6205 million yuan in dividends since its A-share listing, with 40.1089 million yuan distributed over the past three years [3] Stock Performance - As of October 14, Titan Technology's stock price decreased by 2.04% to 24.53 yuan per share, with a market capitalization of 4.034 billion yuan [1] - Year-to-date, the stock price has increased by 35.00%, with a slight increase of 0.74% over the last five trading days, a decrease of 3.12% over the last 20 days, and an increase of 0.33% over the last 60 days [1] Shareholder Information - As of June 30, the number of shareholders increased by 12.61% to 7,718, while the average circulating shares per person decreased by 11.19% to 21,305 shares [2] Industry Classification - Titan Technology belongs to the Shenwan industry classification of basic chemicals - chemical products - other chemical products, and is associated with concepts such as small-cap stocks, pension concepts, margin financing, and buybacks [2]
泰坦科技股价连续8天下跌累计跌幅19.16%,融通基金旗下1只基金持116.09万股,浮亏损失670.98万元
Xin Lang Cai Jing· 2025-09-04 07:37
Group 1 - Titan Technology's stock price has declined for eight consecutive days, with a total drop of 19.16%, currently trading at 24.38 CNY per share and a market capitalization of 4.009 billion CNY [1] - The company, established in October 2007 and listed in October 2020, provides integrated technical solutions for scientific services, including research reagents, biological consumables, analytical consumables, laboratory instruments, and specialized chemicals [1] - The revenue composition of Titan Technology includes 25.08% from proprietary specialty chemicals, 20.48% from proprietary high-end reagents, and 15.65% from third-party research instruments and consumables [1] Group 2 - Rongtong Fund holds 1.161 million shares of Titan Technology in its Rongtong Healthcare Industry Mixed Fund A/B, representing 3.28% of the fund's net value, making it the ninth largest holding [2] - During the eight-day decline, the fund has incurred a floating loss of approximately 670.98 thousand CNY [2] - The Rongtong Healthcare Industry Mixed Fund A/B has achieved a year-to-date return of 22.05% and a one-year return of 33.89% [2] Group 3 - The fund managers of Rongtong Healthcare Industry Mixed Fund A/B are Wan Minyuan and Liu Xiyang, with Wan having a tenure of nearly 10 years and a best fund return of 157.54% during his management [3] - Liu Xiyang has been managing the fund for about 1.5 years, with a best fund return of 4.17% during his tenure [3]